KD Logo

Insider Selling: Coulie Bernard, Pliant Therapeutics Inc [PLRX] President and CEO divested 25,721 shares

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pliant Therapeutics Inc shares valued at $443,173 were sold by Coulie Bernard on Jan 17 ’24. At $17.23 per share, Coulie Bernard sold 25,721 shares. The insider’s holdings dropped to 316,382 shares worth approximately $3.4 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Also, Lefebvre Eric sold 10,295 shares, netting a total of over 177,383 in proceeds. Following the sale of shares at $17.23 each, the insider now holds 156,920 shares.

Before that, Hull Hans had sold 9,786 shares from its account. In a trade valued at $168,613, the Chief Business Officer traded Pliant Therapeutics Inc shares for $17.23 each. Upon closing the transaction, the insider’s holdings decreased to 9,786 shares, worth approximately $1.99 million.

As published in their initiating research note from Wells Fargo on December 08, 2023, Pliant Therapeutics Inc [PLRX] has been an Overweight and the price target has been revised to $41. Analysts at Canaccord Genuity started covering the stock with ‘”a Buy”‘ outlook in a report released in mid May. As of April 13, 2023, Robert W. Baird has initiated its “an Outperform” rating for PLRX. Earlier on December 14, 2022, Stifel initiated its rating. Their recommendation was “a Buy” for PLRX stock.

Analyzing PLRX Stock Performance

During the last five days, there has been a drop of approximately -8.50%. Over the course of the year, Pliant Therapeutics Inc shares have dropped approximately -40.59%. Shares of the company reached a 52-week high of $19.62 on 01/08/24 and a 52-week low of $10.43 on 06/18/24. A 50-day SMA is recorded $12.88, while a 200-day SMA reached $15.11. Nevertheless, trading volume fell to 0.53 million shares from 0.32 million shares the previous day.

Support And Resistance Levels for Pliant Therapeutics Inc (PLRX)

According to the 24-hour chart, there is a support level at 10.57, which, if violated, would cause prices to drop to 10.38. In the upper region, resistance lies at 10.90. The next price resistance is at 11.04. RSI (Relative Strength Index) is 32.56 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.69, which suggests the price will decrease in the coming days. Percent R is at 86.42%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular